Newsletter

326030 - SK biopharmaceuticals Co., Ltd.

326030 Summary
Biopharma
Stock Price & Overview
₩86,600 +200 (+0.23%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩86,600  ≈ US$62  ·  Market cap ₩6.8tn (≈ $4.8bn)
Home › 326030 › Filings

Supplier Payment Terms and Dispute-Resolution Disclosure

DART
SK biopharmaceuticals Co., Ltd.
Filed Aug 14, 2026 KST · Governance · receipt 20260814000403

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항

326030

Price
₩86,600
Change
+0.23%
Market cap
₩6.8tn
Prev. close
₩86,400
326030 SummaryCompare to Peers

More 326030 filings

Change in the Largest Shareholder's Holdings

08/31/26

Insider / Major Shareholder Holdings Report ×2

08/31/26

Large business group status disclosure — quarterly, individual company

08/27/26

Material event report (significant asset transfer, other)

08/26/26

Investor Relations Event

08/26/26

Material matter: in-licensing deal for Opakalim and other epilepsy drug candidates

08/26/26